Back
Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison
Sell
23
ALPMY
Astellas Pharma
Last Price:
10.09
Seasonality Move:
1.82%
Sell
49
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
18.65%
Sell
23
Astellas Pharma (ALPMY)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMY] share price is $10.09. The Score for ALPMY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ALPMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALPMY Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $10.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
ALPMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 27.62 | Sell |
Chaikin Money Flow: | 134690 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.52 - 11.72) | Sell |
Bollinger Bands (100): | (10.69 - 12.17) | Sell |
SOLTF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 52.73 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.37 - 8.05) | Buy |
Bollinger Bands (100): | (7.99 - 10.09) | Sell |
ALPMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.37 | Sell |
20-day SMA: | 11.02 | Sell |
50-day SMA: | 11.46 | Sell |
200-day SMA: | 10.83 | Sell |
8-day EMA: | 10.37 | Sell |
20-day EMA: | 10.82 | Sell |
50-day EMA: | 11.23 | Sell |
200-day EMA: | 11.37 | Sell |
SOLTF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.05 | Sell |
20-day SMA: | 7.75 | Buy |
50-day SMA: | 8.28 | Sell |
200-day SMA: | 9.4 | Sell |
8-day EMA: | 8.02 | Buy |
20-day EMA: | 7.95 | Buy |
50-day EMA: | 8.25 | Sell |
200-day EMA: | 9.38 | Sell |
Astellas Pharma Earnings Growth & ALPMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nxera Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |